EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Nasal humoral immunity: the first line of protection against respiratory pathogens

Lena Hansen, Jenna J Guthmiller iD

ImmunoHorizons · 22.04.2026 · 10 (4)

DOI: 10.1093/immhor/vlaf076 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ImmunoHorizons, online erschienen am 26.04.2026. Verfasst von Lena Hansen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Hauptthemen laut MEDLINE: Immunity, Humoral, Nasal Cavity, Respiratory Tract Infections. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, ODCDC CDC HHS, National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nasal cavity is the first site of infection for respiratory pathogens, and control of pathogens at this site is critical for limiting disease progression. Mucosal immunity in the respiratory tract has historically been studied in the lungs despite lung infections typically arising as a result of lack of pathogen control in the upper respiratory tract. However, the generation of vaccines to prevent infection and block transmission requires an understanding of how immune responses are generated and maintained within the nasal cavity. Recently, a concerted research effort to understand immune responses in the nasal cavity and upper respiratory tract has revealed new insight into how local immune responses are generated and help to control respiratory pathogens. Here, we discuss these recent advances and outstanding questions in our understanding of humoral immunity within the nasal cavity and upper respiratory tract.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, HumoralNasal CavityRespiratory Tract InfectionsHumansAnimalsImmunity, Mucosal

Stichwörter der Autor:innen

antibodieshumoral immunityplasma cells

Autor:innen und Institutionen

  • Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

ORCID-Profile: Jenna J Guthmiller

Förderung

  • NIH HHS
  • ODCDC CDC HHS
  • National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers

Zitieren

APA

Hansen, L., & Guthmiller, J. J. (2026). Nasal humoral immunity: the first line of protection against respiratory pathogens. ImmunoHorizons, 10(4). https://doi.org/10.1093/immhor/vlaf076

Vancouver

Hansen L, Guthmiller JJ. Nasal humoral immunity: the first line of protection against respiratory pathogens. ImmunoHorizons. 2026;10(4). doi:10.1093/immhor/vlaf076

BibTeX
@article{Hansen2026,
  author = {Hansen, Lena and Guthmiller, Jenna J},
  title = {Nasal humoral immunity: the first line of protection against respiratory pathogens},
  journal = {ImmunoHorizons},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1093/immhor/vlaf076}
}
Kostenlos starten →